| 25 May 2026 |
Retatrutide |
7.5 |
15mg |
15.6mg |
+4.0% |
99.70% |
Lab G |
| 25 May 2026 |
Flibanserin |
6.3 |
50mg |
59.4mg |
+18.8% |
96.39% |
Lab A |
| 25 May 2026 |
Tamoxifen (Nolvadex) |
7.3 |
20mg |
24.5mg |
+22.3% |
99.64% |
Lab B |
| 25 May 2026 |
Trenbolone Acetate Raw |
8.0 |
5g |
5.7g |
+13.3% |
99.42% |
Lab D |
| 24 May 2026 |
Boldenone Cypionate |
5.7 |
100mg/ml |
103.3mg/ml |
+3.3% |
95.94% |
Lab A |
| 24 May 2026 |
Bronchogen |
5.9 |
50mg |
53.7mg |
+7.5% |
96.69% |
Lab C |
| 24 May 2026 |
Bronchogen |
8.2 |
20mg |
22.8mg |
+13.8% |
97.68% |
Lab D |
| 24 May 2026 |
Tadalafil (Cialis) |
6.7 |
20mg |
23.2mg |
+16.0% |
97.30% |
Lab F |
| 24 May 2026 |
Retatrutide |
6.3 |
10mg |
10.8mg |
+8.0% |
99.60% |
Lab G |
| 24 May 2026 |
GHK-Cu |
5.0 |
50mg |
58mg |
+16.0% |
99.70% |
Lab G |
| 24 May 2026 |
Retatrutide |
8.0 |
10mg |
10.1mg |
+1.0% |
99.90% |
Lab E |
| 24 May 2026 |
Retatrutide |
8.0 |
5mg |
4.84mg |
-3.2% |
99.90% |
Lab E |
| 24 May 2026 |
Flibanserin |
5.6 |
100mg |
99.6mg |
-0.4% |
97.18% |
Lab A |
| 24 May 2026 |
PE 22-28 |
5.8 |
15mg |
18.3mg |
+22.0% |
98.36% |
Lab E |
| 24 May 2026 |
SS-31 |
7.7 |
2mg |
2.1mg |
+5.8% |
96.85% |
Lab B |
| 24 May 2026 |
T4 (Levothyroxine) |
6.6 |
25mg |
28.5mg |
+13.8% |
97.08% |
Lab A |
| 24 May 2026 |
Tamoxifen (Nolvadex) |
5.2 |
10mg |
11.1mg |
+11.0% |
99.05% |
Lab E |
| 24 May 2026 |
Retatrutide |
3.5 |
10mg |
8.76mg |
-12.4% |
98.54% |
Lab E |
| 24 May 2026 |
Retatrutide |
9.1 |
50mg |
48mg |
-4.0% |
99.53% |
Lab E |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.8 |
2mg |
2.0mg |
-1.3% |
97.47% |
Lab F |
| 24 May 2026 |
Estradiol Cypionate |
7.3 |
200mg/ml |
196.6mg/ml |
-1.7% |
99.38% |
Lab A |
| 24 May 2026 |
KPV Oral |
5.4 |
25mg |
29.0mg |
+15.9% |
97.24% |
Lab F |
| 24 May 2026 |
Lipo-B 216mg |
4.8 |
200mg/ml |
199.8mg/ml |
-0.1% |
99.86% |
Lab A |
| 24 May 2026 |
AICAR |
6.7 |
50mg |
43.2mg |
-13.5% |
95.64% |
Lab C |
| 24 May 2026 |
Alprostadil |
8.0 |
50mg |
57.0mg |
+14.0% |
95.62% |
Lab F |
| 24 May 2026 |
Bronchogen |
10.0 |
30mg |
36.3mg |
+21.1% |
96.40% |
Lab B |
| 24 May 2026 |
Cerebrolysin |
6.5 |
2mg |
1.8mg |
-12.1% |
97.98% |
Lab F |
| 24 May 2026 |
Cerebrolysin |
4.0 |
15mg |
15.0mg |
+0.1% |
95.19% |
Lab C |
| 24 May 2026 |
AHK-CU |
5.4 |
30mg |
26.6mg |
-11.3% |
97.76% |
Lab G |
| 24 May 2026 |
Boldenone Cypionate |
6.8 |
300mg/ml |
308.3mg/ml |
+2.8% |
96.77% |
Lab B |
| 24 May 2026 |
GHRP-6 Acetate |
6.2 |
5mg |
5.4mg |
+8.3% |
98.12% |
Lab F |
| 24 May 2026 |
Retatrutide 30mg Pen Kit |
7.3 |
50mg |
58.0mg |
+16.0% |
98.85% |
Lab G |
| 24 May 2026 |
Trenbolone Acetate Raw |
8.1 |
500g |
555.6g |
+11.1% |
96.21% |
Lab E |
| 23 May 2026 |
Finasteride |
8.0 |
20mg |
19.7mg |
-1.4% |
96.34% |
Lab B |
| 23 May 2026 |
GHRP-6 Acetate |
10.0 |
10mg |
8.9mg |
-11.3% |
98.20% |
Lab B |
| 23 May 2026 |
Tren Hex |
7.5 |
250mg/ml |
225.9mg/ml |
-9.6% |
98.23% |
Lab G |
| 23 May 2026 |
AICAR |
8.2 |
15mg |
13.4mg |
-10.4% |
96.15% |
Lab F |
| 23 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.2 |
15mg |
16.1mg |
+7.1% |
98.14% |
Lab F |
| 23 May 2026 |
HMG |
6.4 |
2mg |
1.8mg |
-8.4% |
95.06% |
Lab C |
| 23 May 2026 |
Ovagen |
6.1 |
10mg |
9.2mg |
-8.1% |
95.91% |
Lab F |
| 23 May 2026 |
SS-31 |
6.7 |
30mg |
27.7mg |
-7.5% |
96.95% |
Lab C |
| 21 May 2026 |
Anavar (Oxandrolone) |
5.9 |
50mg |
62.0mg |
+23.9% |
98.42% |
Lab G |
| 21 May 2026 |
Bronchogen |
7.4 |
50mg |
45.7mg |
-8.7% |
96.18% |
Lab B |
| 21 May 2026 |
HMG |
7.3 |
30mg |
32.7mg |
+9.0% |
98.78% |
Lab E |
| 21 May 2026 |
Equipoise (Boldenone Undecylenate) |
7.6 |
100mg/ml |
123.9mg/ml |
+23.9% |
95.93% |
Lab G |
| 21 May 2026 |
Flibanserin |
4.5 |
10mg |
11.3mg |
+13.4% |
95.37% |
Lab F |
| 21 May 2026 |
KPV Oral |
6.0 |
10mg |
11.2mg |
+12.1% |
99.72% |
Lab B |
| 21 May 2026 |
Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) |
4.7 |
100mg/ml |
98.5mg/ml |
-1.5% |
95.28% |
Lab B |
| 20 May 2026 |
AICAR |
5.4 |
10mg |
11.1mg |
+11.3% |
95.91% |
Lab F |
| 20 May 2026 |
Boldenone Cypionate |
5.2 |
200mg/ml |
195.1mg/ml |
-2.4% |
96.87% |
Lab E |
| 20 May 2026 |
Cerebrolysin |
5.4 |
10mg |
11.7mg |
+17.5% |
99.87% |
Lab G |
| 20 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.4 |
2mg |
2.2mg |
+11.1% |
96.91% |
Lab C |
| 20 May 2026 |
Flibanserin |
6.1 |
20mg |
18.1mg |
-9.4% |
99.20% |
Lab E |
| 19 May 2026 |
GHRP-6 Acetate |
6.9 |
10mg |
8.6mg |
-13.9% |
95.08% |
Lab E |
| 19 May 2026 |
MK-677 (Ibutamoren) |
6.0 |
50mg |
60.4mg |
+20.9% |
98.80% |
Lab E |
| 17 May 2026 |
Equipoise (Boldenone Undecylenate) |
5.4 |
300mg/ml |
293.7mg/ml |
-2.1% |
97.45% |
Lab E |
| 17 May 2026 |
HMG |
6.8 |
15mg |
13.9mg |
-7.1% |
99.29% |
Lab C |
| 17 May 2026 |
Sustanon Blend Raw |
5.1 |
500g |
608.9g |
+21.8% |
95.10% |
Lab D |
| 17 May 2026 |
Trenbolone Acetate Raw |
7.2 |
500g |
611.6g |
+22.3% |
97.06% |
Lab A |
| 29 Jan 2026 |
Lipo-B 216mg |
9.0 |
100mg/ml |
100.5mg/ml |
+0.5% |
99.10% |
Lab G |
| 29 Jan 2026 |
T4 (Levothyroxine) |
6.8 |
10mg |
11.1mg |
+10.9% |
99.27% |
Lab E |
| 26 Jan 2026 |
DSIP |
8.0 |
10mg |
10.9mg |
+9.2% |
96.66% |
Lab A |
| 19 Jan 2026 |
Anavar (Oxandrolone) |
7.5 |
50mg |
54.1mg |
+8.1% |
96.05% |
Lab D |
| 19 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.1 |
5mg |
5.8mg |
+16.0% |
97.06% |
Lab C |
| 19 Jan 2026 |
GHRP-6 Acetate |
8.1 |
50mg |
48.9mg |
-2.2% |
95.63% |
Lab D |
| 19 Jan 2026 |
Lipo-B 216mg |
7.0 |
100mg/ml |
109.6mg/ml |
+9.6% |
98.41% |
Lab F |
| 19 Jan 2026 |
T4 (Levothyroxine) |
4.0 |
20mg |
17.2mg |
-14.0% |
97.16% |
Lab A |
| 9 Jan 2026 |
Alprostadil |
9.8 |
2mg |
2.4mg |
+20.3% |
99.05% |
Lab E |
| 9 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
8.3 |
2mg |
1.8mg |
-10.4% |
95.63% |
Lab G |
| 9 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.8 |
30mg |
33.9mg |
+13.1% |
97.50% |
Lab G |
| 9 Jan 2026 |
PE 22-28 |
7.5 |
10mg |
11.4mg |
+14.3% |
95.67% |
Lab D |
| 7 Jan 2026 |
Equipoise (Boldenone Undecylenate) |
6.6 |
100mg/ml |
90.1mg/ml |
-9.9% |
97.54% |
Lab E |
| 7 Jan 2026 |
Estradiol Cypionate |
8.7 |
250mg/ml |
259.1mg/ml |
+3.7% |
98.63% |
Lab E |
| 7 Jan 2026 |
Selank |
4.7 |
20mg |
23.8mg |
+18.8% |
98.17% |
Lab F |
| 6 Jan 2026 |
DSIP |
8.2 |
50mg |
54.5mg |
+9.1% |
95.18% |
Lab G |
| 6 Jan 2026 |
KPV Oral |
7.6 |
20mg |
19.1mg |
-4.3% |
96.66% |
Lab E |
| 6 Jan 2026 |
PE 22-28 |
6.1 |
30mg |
34.4mg |
+14.7% |
99.80% |
Lab A |
| 6 Jan 2026 |
Trenbolone Acetate Raw |
6.9 |
500g |
614.2g |
+22.8% |
97.98% |
Lab A |
| 29 Dec 2025 |
Anavar (Oxandrolone) |
7.8 |
25mg |
29.9mg |
+19.5% |
95.27% |
Lab E |
| 29 Dec 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
8.7 |
15mg |
15.6mg |
+3.9% |
95.81% |
Lab A |
| 29 Dec 2025 |
Finasteride |
6.2 |
100mg |
113.1mg |
+13.1% |
99.40% |
Lab C |
| 29 Dec 2025 |
GHRP-6 Acetate |
7.0 |
15mg |
16.3mg |
+8.9% |
98.76% |
Lab A |
| 29 Dec 2025 |
HMG |
9.3 |
15mg |
15.2mg |
+1.1% |
99.30% |
Lab A |
| 29 Dec 2025 |
N-Acetyl Epitalon Amidate |
7.0 |
50mg |
46.1mg |
-7.8% |
96.70% |
Lab A |
| 29 Dec 2025 |
Retatrutide 30mg Pen Kit |
7.7 |
5mg |
4.6mg |
-7.3% |
95.22% |
Lab C |
| 29 Dec 2025 |
Selank |
5.1 |
15mg |
15.3mg |
+2.1% |
99.41% |
Lab A |
| 29 Dec 2025 |
Tamoxifen (Nolvadex) |
5.5 |
10mg |
9.9mg |
-1.3% |
96.50% |
Lab F |
| 12 Dec 2025 |
Alprostadil |
6.3 |
50mg |
47.9mg |
-4.3% |
98.24% |
Lab E |
| 12 Dec 2025 |
Selank |
5.1 |
5mg |
5.4mg |
+7.6% |
99.03% |
Lab G |
| 12 Dec 2025 |
SS-31 |
8.6 |
10mg |
10.5mg |
+4.8% |
98.85% |
Lab G |
| 12 Dec 2025 |
Tadalafil (Cialis) |
7.4 |
20mg |
23.5mg |
+17.6% |
98.47% |
Lab G |
| 5 Dec 2025 |
MK-677 (Ibutamoren) |
6.8 |
100mg |
120.7mg |
+20.7% |
99.20% |
Lab E |
| 5 Dec 2025 |
Tamoxifen (Nolvadex) |
5.0 |
10mg |
11.2mg |
+12.3% |
96.37% |
Lab C |
| 23 Nov 2025 |
Equipoise (Boldenone Undecylenate) |
6.2 |
100mg/ml |
106.5mg/ml |
+6.5% |
97.98% |
Lab B |
| 23 Nov 2025 |
Estradiol Cypionate |
6.9 |
300mg/ml |
369.6mg/ml |
+23.2% |
95.09% |
Lab E |
| 23 Nov 2025 |
MK-677 (Ibutamoren) |
8.6 |
100mg |
85.8mg |
-14.2% |
95.84% |
Lab C |
| 23 Nov 2025 |
Trenbolone Acetate Raw |
7.6 |
500g |
582.0g |
+16.4% |
97.02% |
Lab E |
| 17 Nov 2025 |
Retatrutide 30mg Pen Kit |
8.8 |
2mg |
2.5mg |
+23.4% |
98.93% |
Lab B |
| 17 Nov 2025 |
Tamoxifen (Nolvadex) |
4.0 |
10mg |
8.8mg |
-11.6% |
95.90% |
Lab G |
| 5 Nov 2025 |
DSIP |
7.0 |
5mg |
6.1mg |
+22.8% |
96.61% |
Lab B |
| 5 Nov 2025 |
KPV Oral |
8.1 |
50mg |
51.4mg |
+2.8% |
96.48% |
Lab B |
| 5 Nov 2025 |
Tadalafil (Cialis) |
4.5 |
10mg |
12.4mg |
+23.9% |
99.83% |
Lab E |
| 4 Nov 2025 |
Estradiol Cypionate |
5.9 |
200mg/ml |
244.9mg/ml |
+22.4% |
96.46% |
Lab D |
| 4 Nov 2025 |
PE 22-28 |
6.8 |
15mg |
18.3mg |
+21.9% |
95.37% |
Lab E |
| 4 Nov 2025 |
Retatrutide 30mg Pen Kit |
7.9 |
30mg |
32.1mg |
+6.8% |
97.72% |
Lab A |
| 4 Nov 2025 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
7.7 |
15mg |
17.1mg |
+13.8% |
96.95% |
Lab G |
| 4 Nov 2025 |
SNAP-8 |
6.8 |
30mg |
36.5mg |
+21.6% |
99.62% |
Lab D |
| 4 Nov 2025 |
SS-31 |
4.0 |
10mg |
12.3mg |
+22.9% |
97.54% |
Lab G |
| 17 Oct 2025 |
Pinealon |
4.0 |
30mg |
36.9mg |
+23.1% |
97.56% |
Lab G |
| 17 Oct 2025 |
Retatrutide 30mg Pen Kit |
6.6 |
10mg |
8.8mg |
-12.1% |
95.79% |
Lab F |
| 9 Oct 2025 |
Anavar (Oxandrolone) |
7.7 |
10mg |
9.9mg |
-1.1% |
96.50% |
Lab E |
| 9 Oct 2025 |
DSIP |
8.0 |
20mg |
18.0mg |
-9.9% |
99.20% |
Lab F |
| 9 Oct 2025 |
Selank |
4.0 |
2mg |
2.3mg |
+13.0% |
98.86% |
Lab D |
| 9 Oct 2025 |
Sustanon Blend Raw |
7.3 |
500g |
616.7g |
+23.3% |
98.77% |
Lab C |
| 3 Oct 2025 |
Estradiol Cypionate |
7.6 |
250mg/ml |
275.7mg/ml |
+10.3% |
98.16% |
Lab D |
| 3 Oct 2025 |
PE 22-28 |
4.3 |
15mg |
14.3mg |
-4.4% |
99.02% |
Lab F |